Amedea Pharma

Meet Tim Mikhelashvili, Amedea Pharma Chief Executive Officer, at Bullpen Cup on Monday, January 13 at 11:30 AM during JPM Week 2025 in San Francisco. Learn more about Amedea Pharma: #AmedeaPharma's ANCORA platform uses a unique Deep Metrics method that brings sports & data science into the daily fabric of business to clarify purpose, progress, and reward. It analyzes performance to such detail across Customer + Employee Experience that ensures continuous quality improvement of decisions, strategy, and outcomes. Golden Gate Yacht Club Mon, Jan 13 | 10 am - 1 pm Request an Invitation: https://lnkd.in/gBeEn-jw #BullpenCup Lineup: 10:15 AM | Emily Fang | InFocus Therapeutics 10:45 AM | Jolly Nanda, MBA | Altheia, Inc. 11:00 AM | Dr. Himanshu Misra | EnlitenAI, Inc 11:30 AM | Tim Mikhelashvili | Amedea Pharma 11:45 AM | Robert Neusner | BMI OrganBank 12:00 PM | Priya Baraniak, Ph.D. | Stealth TBA 12: 15 PM | Oleg Shinkazh | ChromaTan, Inc Thank You Sponsor Members: Jeff Steinle | Fredrikson & Byron, P.A. Roberta Antoine D. | Medical Alley Bruce Hunter | University of Utah Technology Licensing Office Mark Stevenson | Veranex Reut Lazo | Women And AI Anthony Ryan | Brisbane Economic Development Agency The purpose of Bullpen Cup is to gather international life science Bullpen Members, Guests and resources at regional life science hubs to support each other as a community of Dealmakers. There is no single winner at Bullpen Cup – we all win. #Bullpen #JPM2025: https://lnkd.in/gcXNSkBA Enjoy a world-class venue with shoreline views of the Golden Gate Bridge and Alcatraz at Bullpen HQ. Lunch is complimentary for accepted investors. Bullpen is an invite-only Club gathering Life Science Investors and CxOs with a shared goal of helping each other. We prepare for and attend premier industry events together. Our #Mantra: Find Someone to Help. Repeat. Mission: https://lnkd.in/gemP3WGC Membership Inquiries: https://lnkd.in/gfnyBEpK Member Roster: https://lnkd.in/gqJA_nKB Full Schedule: https://lnkd.in/giP5dNkR

The Medical Affairs Innovation Olympics, which have taken place every year since 2022 have already brought to the healthcare community incredible advances that have been recognized widely. Our latest 2024 event was no exception with leading innovators and competitors Lika Mumladze Mark Armstrong Jolly Nanda, MBA George Xygkos MANZI NDAMUKUNZE Pierre Daou, MD Lasha Murjikneli, Ph.D. submitting solutions with tremendous, global impact. Subscribe to the Amedea Pharma blog and read the highlights of these innovations we celebrated this year in the article below! Stay tuned with the Amedea Pharma website for details to be posted in January on how to submit your medical innovation concepts and solutions for the 2025 Innovation Olympic Trials in April and how to register for the main event in October next year! https://lnkd.in/eRrdcRbQ #MAIO2024 #healthcareinnovation

The last podcast of the year on the Alloutcoach show (Full episode: https://lnkd.in/eEPwP4mh) shares some of the most memorable stories from the Paris Olympics as well as personal stories and commentary on critical business lessons for a strong 2025 year ahead! Below is a short clip - make sure to watch the full episode, follow Alloutcoach, and share it with your friends to support more learning and development ahead on this show, which was launched in 2019! #biotechinnovation #competitiveedge #parisolympics

Hurry and care can't coexist. To lead someone, you must understand them. To care for someone, you must understand them. True understanding takes time and attention. In my work and research this year, what's stood out to me is how life-giving and energizing being seen is, yet how devastating and draining being overlooked is. Leadership is relationships. That's why the best relationship advice remains the best leadership advice: Show up fully. 📽️ Small Giants Community Summit (May 2024). #leadership #leadershipdevelopment #culture

Let's meet in San Francisco at JPM and get the New 2025 Year started right. If you want to meet, I have an amazing venue at the Golden Gate Yacht Club where we can discuss business and make some deals happen! #JPM #dealmaking #pharma #DataAnalytics

Meet Tim Mikhelashvili in the Bullpen during JPM Week 2025 January 12 - 16 in San Francisco. #JPM2025 Request an Invitation: https://lnkd.in/gcXNSkBA #Bullpen HQ is located at the Golden Gate Yacht Club, home to America's Cup Champion Oracle Team USA. Request an invitation to join us for Gourmet Meals, Investor-Only Meetings, Bullpen Cup Pitches, 1:1 Partnering, KOL Interviews, Golden Gate Bridge Boat Rides and Sunset Happy Hours while gazing directly at the Golden Gate Bridge. #Mantra: Find Someone to Help. Repeat. Bullpen is an invite-only Club gathering Life Science Investors and CxOs with the shared goal of helping each other. We prepare for and attend premier industry events together. 2024 JPM Photos: https://lnkd.in/g6GrGDmY Thank you to our Lead Partners: Ben Kromnick at Mercury Ernesto Chanona at CSSi LifeSciences Jill Sorensen at MTEC | Medical Technology Enterprise Consortium Lisa Cavallaro at Brisbane Economic Development Agency (BEDA) Caley Anderson, MBA at Collaborative Drug Discovery - CDD Vault Jess Hawthorne at CSC Leasing Phillip Ebner at J.P. Morgan James Zanewicz, JD, LLM, RTTP at BIO on the BAYOU Anton Xavier at Silicon Valley Bank Laura Haldane at SciLeads

Make Decisions Based on Real Data Directly, Transparently, and Objectively! Before the Holidays as you set your sights on better decisions and stronger year of performance in 2025 in life sciences, here is a clip of an assessment of what the new ANCORA decision assistant platform from Amedea Pharma can do to transform your strategy next year from our new monthly webinar series Jeff New Luz Andrea Ramirez Alex Pasek, MD. Book a demo to learn more here: https://lnkd.in/ebBfBsiF Watch the replay of the webinar in case you missed it here https://lnkd.in/emGjrTJW. The next one is January 16 - stay tuned. #dataanalytics #datadrivendecisions

Promote the trustworthy, not just the high-performing. Is your team built on trust? 👥 For more: https://lnkd.in/eKEER75B Video from Mercedes-Benz Club, March 2024, in conversation with Arthur Blank

Where Do We Stand on AI Adoption in Healthcare? AI is shaping the future of healthcare, but where is it making an impact today, and what lies ahead? This Medscape & HIMSS Survey tells you how AI is being used, uncovering trends, challenges, and opportunities. Here’s what you need to know: 1. Where AI Is Already Making an Impact AI is predominantly being used for administrative tasks, such as transcription and patient communication. Tools like ambient AI for note-taking offer quick efficiency gains without requiring extensive data integration. However, clinical applications, such as personalized treatment plans, remain less common due to skepticism and the lack of specialized tools. 2. Physicians Experimenting with AI Independently Interestingly, 50% of physicians report using AI tools independently for tasks like analyzing medical literature, diagnosing conditions, or personalizing treatments. This experimentation may influence where healthcare organizations prioritize AI integration. 3. What’s Next for AI in Medicine? AI’s future in healthcare includes reviewing EHRs and medical literature. Yet, the lack of robust digital infrastructure in many hospitals slows progress in advanced applications, such as radiology and clinical decision support. 4. Proven Benefits: Efficiency and Productivity Early adopters report tangible benefits, with 57% of respondents experiencing efficiency and productivity improvements. However, achieving a ROI is complex, and significant cost savings may take time. 5. The Challenge of Training Only 24% of organizations provide AI training programs. This highlights a gap in education and certification, leaving clinicians without the tools to leverage AI’s potential. 6. Data Privacy and Ethical Concerns Data privacy is a top concern, with 72% of respondents expressing worries. Ethical challenges, such as biased algorithms and accountability for AI-driven decisions, are significant, with 70% flagging these as barriers to adoption. 7. Physicians’ Mixed Attitudes Toward AI While AI offers promise, skepticism remains. 60% of physicians worry about malpractice risks, and 70% emphasize ethical dilemmas. Takeaway: AI holds immense promise, but its adoption remains uneven. Early wins are concentrated in administrative efficiencies, while scaling clinical applications and infrastructure upgrades will require time, trust, and targeted investments. To ensure AI enhances human expertise, we must invest in training, address data privacy concerns, and establish ethical frameworks. On a personal note, I believe the path to adoption lies in applying and testing the technology firsthand. For example, I used Copilot to craft this summary, leveraging AI for the “reviewing and analyzing medical literature” use case. I’d love to hear from you: Are you already using AI in your daily life? If so, what’s your preferred use case? Kudos to Christine, Anne, Robert, Albe, Nicole, and the Medscape, and HIMSS teams for this report.

Dear Friends, I am so excited to share my personal review of the 2024 World Business Forum in New York City where I reconnected with former colleagues I had not seen in over 20 years, left inspired from keynotes, and exchanged my opinions with some of the world's most recognized business leaders, management and innovation consultants, and executives such as Gary Hamel Felipe Gomez Jon McNeill Anne Chow (She/Her) Amy Edmondson Stephen M. R. Covey Ethan Kross as well as the Godfather director himself Francis Ford Coppola. Enjoy the valuable insights and case studies from this unforgettable conference and apply them in your life or work whether you are an executive, middle-level manager, team contributor, or student. Subscribe to the InWeekend Newsletter, share it with your friends. Leave your comments below and connect with me and Amedea Pharma to take your team's performance across both customer + employee experience to the next dimension in 2025! ARTICLE OUTLINE 1. MASTERING OUR CREATIVITY THROUGH TENSION AND RELEASE 2. HUMANS ARE GENIUS, DARING, and RESILIENT - NOT ORGANIZATIONS Latest Decline in G7 Labor Productivity despite Growth in IT Spending Recent Organizational Champions in Innovation:      Roche Case Study Buurtzorg Nederland Case Study 3. INTELLIGENT FAILURES IN A COMPLEX WORLD Eli Lilly and Company Case Study - Turning around a Clinical Trial Failure 4. INNOVATION BY SUBTRACTION 5. WHY CULTURE WITH COLLEAGUES DRIVES CUSTOMERS & PROFITS 6. CELEBRATE THE HUMAN EMOTIONS AND ETHICS IN INNOVATION WOBI #wobinyc #leadership #businessinnovation